Log In
Print this Print this

levodopa/carbidopa/entacapone (ODM-101)

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionOptimized formulation of levodopa plus dopa decarboxylase (DDC) inhibitor and catechol-O-methyl-transferase (COMT) inhibitor
Molecular Target
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today